Literature DB >> 21184076

Final pathology findings after immediate or delayed surgery in patients with cytologically benign or follicular thyroid nodules.

Minoru Kihara1, Mitsuyoshi Hirokawa, Yasuhiro Ito, Kaoru Kobayashi, Akihiro Miya, Akira Miyauchi.   

Abstract

BACKGROUND: In the present study, we reviewed our experience with thyroid cytological findings showing benign or follicular tumor and evaluated the outcomes in patients who had undergone immediate or late surgical treatment.
METHOD: In 2007, 445 patients underwent initial surgical therapy for benign or follicular thyroid nodules according to our criteria for surgical indication. Of these, 320 patients underwent thyroid excision immediately. In the remaining 125 patients, surgery was performed after follow-up for more than 18 months.
RESULTS: In this series, the frequencies of finding thyroid carcinoma pathologically were 11.6 and 6.4% in patients undergoing immediate and late surgery, respectively. In these 445 patients, there was no significant difference in age, tumor size, serum thyroglobulin, or nodule growth rate between benign and malignant thyroid nodules. There was, however, a significant difference in ultrasonographic classification.
CONCLUSIONS: Our criteria for surgical indication of nodules diagnosed as cytological benign or follicular tumors were considered appropriate. Ultrasonographic evaluation is an important and useful basis for therapeutic decision making in choosing either immediate surgery or observation for cytologically diagnosed benign or follicular tumors.

Entities:  

Mesh:

Year:  2011        PMID: 21184076     DOI: 10.1007/s00268-010-0907-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  26 in total

1.  Thyroid nodule shape suggests malignancy.

Authors:  Carlo Cappelli; Maurizio Castellano; Ilenia Pirola; Elena Gandossi; Elvira De Martino; Davide Cumetti; Barbara Agosti; Enrico Agabiti Rosei
Journal:  Eur J Endocrinol       Date:  2006-07       Impact factor: 6.664

2.  Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Steven I Sherman; R Michael Tuttle
Journal:  Thyroid       Date:  2006-02       Impact factor: 6.568

3.  Is nodule size an independent predictor of thyroid malignancy?

Authors:  Christopher R McHenry; Eun S Huh; Rhoderick N Machekano
Journal:  Surgery       Date:  2008-12       Impact factor: 3.982

4.  Ultrasound-guided fine-needle aspiration biopsy of thyroid masses.

Authors:  C Carmeci; R B Jeffrey; I R McDougall; K W Nowels; R J Weigel
Journal:  Thyroid       Date:  1998-04       Impact factor: 6.568

5.  Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules.

Authors:  M Sahin; A Gursoy; N B Tutuncu; D N Guvener
Journal:  Clin Endocrinol (Oxf)       Date:  2006-10       Impact factor: 3.478

6.  American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.

Authors:  Hossein Gharib; Enrico Papini; Roberto Valcavi; H Jack Baskin; Anna Crescenzi; Massimo E Dottorini; Daniel S Duick; Rinaldo Guglielmi; Carlos Robert Hamilton; Martha A Zeiger; Michele Zini
Journal:  Endocr Pract       Date:  2006 Jan-Feb       Impact factor: 3.443

7.  Fine-needle aspiration biopsy specimen with a predominance of Hürthle cells: a dilemma in the management of nodular thyroid disease.

Authors:  Diya I Alaedeen; Amer Khiyami; Christopher R McHenry
Journal:  Surgery       Date:  2005-10       Impact factor: 3.982

8.  Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration.

Authors:  R M Tuttle; H Lemar; H B Burch
Journal:  Thyroid       Date:  1998-05       Impact factor: 6.568

9.  Role of ultrasound-guided fine-needle aspiration biopsy in evaluation of nonpalpable thyroid nodules.

Authors:  P Hagag; S Strauss; M Weiss
Journal:  Thyroid       Date:  1998-11       Impact factor: 6.568

10.  Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules: comparison in efficacy according to nodule size.

Authors:  Dong Wook Kim; Eun Joo Lee; Sang Hyo Kim; Tae Hyun Kim; Sang Hyub Lee; Dae Hwan Kim; Myung Ho Rho
Journal:  Thyroid       Date:  2009-01       Impact factor: 6.568

View more
  5 in total

1.  Predictive factors of malignancy in thyroid nodules with a cytological diagnosis of follicular neoplasm.

Authors:  Seong Hyeon Lee; Jeong Su Baek; Joo Young Lee; Jung Ah Lim; Soo Youn Cho; Tae Hyun Lee; Yun Hyi Ku; Hong Il Kim; Min Joo Kim
Journal:  Endocr Pathol       Date:  2013-12       Impact factor: 3.943

2.  Hemithyroidectomy is the preferred initial operative approach for an indeterminate fine needle aspiration biopsy diagnosis.

Authors:  Connie G Chiu; Reina Yao; Simon K Chan; Scott S Strugnell; Samuel Bugis; Robert Irvine; Donald Anderson; Blair Walker; Steven J Jones; Sam M Wiseman
Journal:  Can J Surg       Date:  2012-06       Impact factor: 2.089

3.  Subclassification of follicular neoplasms recommended by the Japan thyroid association reporting system of thyroid cytology.

Authors:  Kennichi Kakudo; Kaori Kameyama; Mitsuyoshi Hirokawa; Ryohei Katoh; Hirotoshi Nakamura
Journal:  Int J Endocrinol       Date:  2015-02-04       Impact factor: 3.257

4.  LC-1000 Flow Cytometry System Improves Risk Stratification of Thyroid Nodules with Suspected Follicular Neoplasm.

Authors:  Ayana Suzuki; Mitsuyoshi Hirokawa; Mitsuru Furutate; Yasuo Hirai; Akira Miyauchi
Journal:  JMA J       Date:  2021-12-24

5.  Criteria for follow-up of thyroid nodules diagnosed as follicular neoplasm without molecular testing - The experience of a high-volume thyroid centre in Japan.

Authors:  Mitsuyoshi Hirokawa; Ayana Suzuki; Makoto Kawakami; Takumi Kudo; Akira Miyauchi
Journal:  Diagn Cytopathol       Date:  2022-02-08       Impact factor: 1.390

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.